ETFs
A
APVO
Aptevo Therapeutics Inc
5.28
-0.33-5.88%After Hours: 5.38 +0.10 +1.90%18:05 04/17 EDT
OPEN/PREV CLOSE5.63/5.61
TODAY RANGE5.26-5.69
VOL690
MARKET CAP6.24M
52 WEEK RANGE3.800-486.00
AVG VOL (3M)58.83K
% TURNOVER1.92%
TURNOVER0
P/E (TTM)-0.0605
% RANGE7.70%
EPS(TTM)-87.2726
P/E(FORWARD)-0.2515
P/B0.3031
BVPS17.42
DIVIDEND--
P/S3.509
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP6.24M
SHARES OUTSTANDING1.18M
NEXT EARNINGS05/12-05/18
FREE FLOAT1.18M
LOT SIZE1
EX-DATE12/30/2025
News
Press Releases
Financial Reports
Profile
TipRanks·03/27 15:25
Roth MKM Sticks to Its Buy Rating for Aptevo Therapeutics (APVO)
TipRanks·03/26 12:20
Aptevo Therapeutics reports FY25 EPS ($87.27) vs. ($31,460.23) last year
TipRanks·03/26 12:20
Aptevo Therapeutics sees cash runway into 4Q26
Seeking Alpha·03/26 12:08
Aptevo Therapeutics GAAP EPS of -$87.27
Reuters·03/23 12:40
Aptevo highlights mipletamig AML data showing 79% remission rate
Reuters·03/19 12:06
Aptevo Therapeutics to present at Roth Conference and BIO-Europe Spring
Benzinga·03/11 17:06
12 Health Care Stocks Moving In Wednesday's Intraday Session
TipRanks·03/11 10:41
Aptevo Reports Promising Interim Data for AML Therapy
TipRanks·03/10 21:55
Roth MKM Keeps Their Buy Rating on Aptevo Therapeutics (APVO)
Benzinga·03/10 17:06
12 Health Care Stocks Moving In Tuesday's Intraday Session
TipRanks·03/10 12:45
Aptevo Therapeutics announces interim data for mipletamig combination
Benzinga·03/02 12:05
10 Health Care Stocks Moving In Monday's Pre-Market Session
Same Industry
Name/Symbol
Change%
Price